« Back
Home /
SSX1 (Human) cDNA (1ug)

SSX1 (Human) cDNA (1ug)

Item no.	ANA10430
Manufacturer	AVIVA Systems Biology
Amount	1ug
Category	Nucleic Acids DNA cDNA
Type	cDNA
Specific against	other
ECLASS 10.1	32160414
ECLASS 11.0	32160414
UNSPSC	41105324
Similar products	SSX1
Available
description	The ORF of human SSX1 is amplified by PCR using a high fidelity enzyme and sub-cloned into a Prokaryotic expression vector under the control of the tac promoter. The expression of the gene has been confirmed by Western blot using an anti-SSX1 polyclonal antibody.
gene_symbol	SSX1
nucleotide_accession_num	http://www.ncbi.nlm.nih.gov/nuccore/BC001003
gene_id	6756
reconstitution_and_storage	Centrifuge the vials after receiving and add 5 ?l ddH2O
description_of_target	The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X, 18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1ug

available

Delivery expected until 8/30/2024